Certican 0,5 mg tablete
Name | Certican 0,5 mg tablete |
---|---|
Marketing Authorisation Number | HR-H-592546271 |
Active Substance | everolimus |
Composition | jedna tableta sadrži 0,5 mg everolimusa |
Pharmaceutical Form | tableta |
Manufacturer | Novartis Pharma GmbH, Nürnberg, Njemačka Novartis Farmacéutica S.A., Barcelona, Španjolska Sandoz S.R.L., Targu Mures, Rumunjska |
Marketing Authorisation Holder | Novartis Hrvatska d.o.o., Radnička cesta 37b, Zagreb, Hrvatska |
Marketing Authorisation Date | 22.09.2016 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/16-02/115 |
Registration Number | 381-12-01/38-16-03 |
Prescription | na recept |
Type of prescription | ograničeni recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | L04AH02 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |
Public Assessment Report | download |